top of page

Latus Therapeutics Limited, founded in 2019, is a leading research and experimental development biotech company with a vision to find a cure for cancer. We are specifically looking at the B-cell Lymphomas and autoimmune disorders in order to get a better understanding of the underlying signalling mechanism of the cell and its potential in helping people to combat cancer.

During the pandemic, Latus Therapeutics refocused its efforts to create a not-for-profit initiative to find a treatment for patients who tested positive for COVID-19. At a time when thousands of people around the world were dying every day from the disease and economies were paralysed, this crucial initiative utilised existing medicines that had already been shown to prevent the virus from infecting human cells in vitro. Latus' team contributed their time for free.

  • LinkedIn


Managing Director of the 

Latus Therapeutics

Screen Shot 2020-05-05 at 14.17.21.png

Dr S. Anthony

Clinical Advisor

Honorary Senior Clinical Lecturer in Radiology, 

Oxford University Hospital


Prof. D. Anthony

Scientific Advisor

Department of Pharmacology, 

University of Oxford


Scientific Advisor

Chairman of Oxford Drug Design

Founder of Oxford University Innovation

Ex-Head of Chemistry Department, 

University of Oxford

Screen Shot 2020-05-05 at 14.17.08.png

Dr C. Ferrett

Trial Coordinator

Consultant Radiologist

Oxford University Hospital

Screen Shot 2020-05-05 at 14.17.35.png

Dr E. Ladds

Clinical Advisor

Academic Clinical Fellow, Primary Care,

Oxford University



Contact us

bottom of page